73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
The role of p53 as a target for novel cancer therapies

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157
Researchers target mutation that leads to pancreatic cancer

Researchers target mutation that leads to pancreatic cancer

by Leslie Cantu,Medical University of South CarolinaCrystal structures of 12D5(K63S) in complex with KRAS(G12D)•GTPγS and with KRAS(G12D)•GDP. (A) A comparison of 12D5(K63S)–KRAS(G12D)•GTPγS (Le

Researchers target mutation that leads to pancreatic cancer

by Leslie Cantu,Medical University of South CarolinaCrystal structures of 12D5(K63S) in complex with KRAS(G12D)•GTPγS and with KRAS(G12D)•GDP. (A) A comparison of 12D5(K63S)–KRAS(G12D)•GTPγS (Le
Patients with HPV-positive oropharynx cancer should receive chemoradiation

Patients with HPV-positive oropharynx cancer should receive chemoradiation

byEuropean Society for Medical OncologyProf Hisham Mehanna, Chair, Head and Neck Surgery, Institute of Cancer and Genomic Sciences, University of Birmingham, UK, study author. Credit: © European

Patients with HPV-positive oropharynx cancer should receive chemoradiation

byEuropean Society for Medical OncologyProf Hisham Mehanna, Chair, Head and Neck Surgery, Institute of Cancer and Genomic Sciences, University of Birmingham, UK, study author. Credit: © European
New AI model detects 90% of lymphatic cancer cases

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No
Genetic discovery could improve treatment of colorectal cancer

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in
U.S. cancer deaths decline overall, but prostate cancers make rebound

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi
Surgery first for colon cancer? Not so fast, according to new study

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li
Examining how gender inequalities worsen women's access to cancer prevention, detection and care

Examining how gender inequalities worsen women's access to cancer prevention, detection and care

by LancetWomen, power, and cancer: a Lancet Commission highlights how, at all these intersections with cancer, women across the globe are subject to overlapping forms of discrimination and inequi

Examining how gender inequalities worsen women's access to cancer prevention, detection and care

by LancetWomen, power, and cancer: a Lancet Commission highlights how, at all these intersections with cancer, women across the globe are subject to overlapping forms of discrimination and inequi
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

by Pohang University of Science & Technology (POSTECH)Credit: POSTECHAccording to Statistics Korea, cancer is the top cause of death in 2021, accounting for 26% of deaths. Most cancer patients mis

Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

by Pohang University of Science & Technology (POSTECH)Credit: POSTECHAccording to Statistics Korea, cancer is the top cause of death in 2021, accounting for 26% of deaths. Most cancer patients mis
Double testing better at identifying bowel cancer

Double testing better at identifying bowel cancer

byUniversity of EdinburghReceiver operating characteristic (ROC) curve analysis for the detection of colorectal cancer between cohorts. Area under the curve 0.85 (95% c.i. 0.80 to 0.90) for the

Double testing better at identifying bowel cancer

byUniversity of EdinburghReceiver operating characteristic (ROC) curve analysis for the detection of colorectal cancer between cohorts. Area under the curve 0.85 (95% c.i. 0.80 to 0.90) for the
Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv